TherapeuticsMD Issues Regulatory Update On TX-004HR: Co. Received Formal General Advice Letter From FDA Stating Initial Review Of Info Has Been Completed, Is Requesting Co. Submit Added Endometrial Safety Info To NDA

Never miss a trade again with the fastest news alerts in the world!

This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday.

Want the fastest, most accurate stock market intelligence? Want EXCLUSIVE stories originated by Benzinga reporters? Join 10,000+ serious traders in the Benzinga Pro community!